ADA 2021: Study Finds Hospitalization Rates for New-onset Pediatric T2D Doubled During Pandemic
Data released today at the American Diabetes Association 81st Scientific Sessions on a spike in new onset pediatric T2D at a single center during COVID-19 may signal much wider incidence.
ADA 2021 Symposia Focus on Health Disparities Exposed and Deepened by COVID-19 Pandemic
Leading international diabetes researchers and clinicians will use the ADA's 81st annual Scientific Sessions as an ideal classroom to examine pandemic impact on diverse populations with diabetes.
ADA Virtual Meeting Will Offer 5 Symposia on Latest COVID-19 Findings
The upcoming ADA virtual 81st Scientific Sessions will feature 5 sessions on the latest diabetes developments learned during the initial phases of the COVID-19 pandemic.
Clinical Trial Updates at the ADA Scientific Sessions 2021: A few primary care musts
The American Diabetes Association 2021 Scientific Sessions run from June 25 to 29. This short slide show highlights 6 clinical trial updates that are a "must see" for primary care clinicians.
ACC.21: High- and Low-Dose Aspirin Both Effective for Patients with Established Cardiovascular Disease
ACC.21: There was no difference found between high- and low-dose aspirin in terms of effectiveness and safety in patients with established CVD, according to new research.
ACC.21: Survival After MI Far Worse for Black Patients from Disadvantaged Neighborhoods
ACC.21: Black patients from disadvantaged neighborhoods were found almost 20% more likely to die within 5 years of MI than white patients from well-resourced ones in a new study.
ATS 2021: Tezepelumab Reduces Exacerbations in Oral Corticosteroid-dependent Patients with Severe Asthma
ATS 2021: In a subgroup of oral corticosteroid-dependent patients with severe asthma from the newly released NAVIGATOR study, tezepelumab reduced exacerbations and improved lung function.
ATS.2021: Study Finds Odds of Uncontrolled Asthma Increase with Higher Pandemic-related Stress
ATS.2021: Odds of uncontrolled asthma in response to pandemic-related stress increased in a significant dose-response manner among adult respondents to a new survey.
ACC.21: Prediabetes Significantly Increases Risk for MACE, According to New Findings
ACC.21: Findings from a study released in advance of the ACC annual meeting suggest that prediabetes confers nearly twice the risk of major cardiovascular events vs normoglycemia.
ATS.2021: At-risk Asthma Phenotypes Defined Using 4 Simple Metrics
ATS.2021. Study authors categorized asthma patients using age at onset, T2 biomarkers, and IL-6 levels, creating 12 phenotypes for additional study.
ATS 2021: Severe COPD Exacerbations May be Associated with Increased Mortality Risk
ATS 2021: The risk of morbidity and death in patients with COPD increases among those with moderate exacerbation, and even more so for severe exacerbation, new research suggests.
ATS 2021: Researchers Project Burden of COPD Will be Worse in 2050, Especially in US
In an abstract being presenting at the upcoming ATS 2021 International Conference, researchers estimate that by 2050 the US will lead the Americas in prevalence of COPD.
Black Women at Risk Early in Life for Future Cardiovascular Disease
ACC.21: High rates of obesity, hypertension, and hyperlipidemia found in Black women in their 20s and 30s are of significant concern, says the author of a study to be presented at the ACC meeting.
ATS 2021: Triple Combination Therapy May Benefit “Wide Spectrum” of Patients with COPD
American Thoracic Society 2021 International Conference: In a subset of patients from the ETHOS study, triple combination therapy was found beneficial for those with moderate COPD.
ACP: Lessons Learned during COVID-19 Pandemic
CDC Director Rochelle Walensky, MD MPH, was a featured presenter at the recent ACP Internal Medicine Meeting 2021: Virtual Experience, where she spoke about lessons learned during COVID-19.
ACP: Clyde Yancy, MD, MSc Reviews Advances in Heart Failure Research and Treatment
ACP: Clyde W Yancy, MD, gave a comprehensive update on a year's worth of pivotal science in treatment of heart failure. Here are the highlights.
Fauci: Widespread COVID-19 Vaccination, Precautions Key to Ending Pandemic
The NIAID head said the timing of the end of the pandemic is really up to the public.
Early Intervention in Weight Management: Treating Pre-Obesity
Research shows that increased risk of chronic disease and mortality begins below a BMI classified as obesity. The earlier we intervene with at-risk patients, the greater the chance for success.
A Weight-centric Approach to Obesity with T2D: How Pharmacotherapy Works
For frontline clinicians who care daily for patients with obesity and type 2 diabetes, a weight-centric approach to T2D, including antiobesity drugs, could help improve outcomes.
These Two Words Could Change Obesity Treatment, says Harold Bays, MD
Long time cardiometabolic investigator Harold Bays, MD, talks about obesity, new drugs to treat the disease, and how the words "be inefficient" could change thinking about treatment.
